SOLUBLE ST2 AND CD163 AS POTENTIALBIOMARKERS TO DIFFERENTIATE PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS FROM MACROPHAGE ACTIVATION SYNDROME. Mediterr J Hematol Infect Dis [Internet]. 2019 Jan. 1 [cited 2026 May 17];11(1):e2019008. Available from: https://www.mjhid.org/mjhid/article/view/2019.008